期刊文献+

聚蛋白多糖酶和基质金属蛋白酶在骨关节炎不同时期关节液中的表达 被引量:6

Expressions of aggrecanase and matrix metalloproteinase in synovial fluid of patients with different stages of osteoarthritis
原文传递
导出
摘要 目的观察比较聚蛋白多糖酶和基质金属蛋白酶MMP-1、3在骨关节炎(OA)不同时期关节液中的表达及作用。方法选择144例膝关节OA患者,软骨退变根据MRI Recht分级标准和关节镜下Outerbridge分级标准进行分级,并根据分级结果分为早、中、晚期3组。采用酶联免疫吸附法及蛋白免疫印迹法分别对3组关节液ADAMTS-4、5和MMP-1、3及其降解产物ARGxx、FFGxx的表达水平进行测定及比较。结果 ADAMTS-4、5在早期和晚期OA关节液中表达明显升高,且ADAMTS-4在早期OA组表达显著高于晚期OA组(P<0.01);与中期OA组相比,MMP-1在晚期OA关节液中高表达,而MMP-3在早期OA关节液中高表达(P<0.05);ARGxx在早期OA关节液中显著高表达(P<0.01),而FFGxx则主要表现在晚期OA关节液中(P<0.01);3组OA关节液中ADAMTS-5、MMP-3、ARGxx的表达水平均分别高于相应各组关节液中ADAMTS-4、MMP-1、FFGxx的表达(P<0.01)。ADAMTS-4和ADAMTS-5的表达均与ARGxx呈正相关(P<0.01),但ADAMTS-4与ARGxx的相关性(r=0.530)高于ADAMTS-5(r=0.258)。蛋白免疫印迹分析结果显示,ADAMTS-4在早期OA组高表达(P<0.05),ADAMTS-5在早期和晚期OA组高表达(P<0.05);MMP-1及FFGxx在晚期OA组高表达(P<0.05);MMP-3在早期OA组的表达量高于中期OA组(P<0.05);ARGxx在早、晚期OA组的表达量显著高于中期OA组(P<0.05)。结论聚蛋白多糖酶在骨关节炎早期和晚期软骨破坏中均起作用,而基质金属蛋白酶主要在晚期起作用。 Objective To compare the different effects of aggrecanases and MMPs by detecting the expression of AD- AMTS-4, ADAMTS-5, MMP-1, MMP-3 proteins in the synovial fluid (SF) of patients with different stages of osteo- arthritis (OA). Methods A total of 144 patients with knee OA were studied and the patients were divided into early-, middle- and late-stage OA groups according to the degree of knee articular cartilage degeneration which was assessed by Recht's grading standard of MRI image and Outerbridge grading standard under arthroscope. Expressions of ADAMTS- 4, ADAMTS-5, MMP-1, MMP-3, ARGxx and FFGxx in the SF were investigated and compared by enzyme-linkedimmunosorbent assay and Western blot. Results Both ADAMTS-4 and ADAMTS-5 had higher expressions in the ear- ly- and late-stage OA groups than those in the middle-stage group, while the expression of ADAMTS-4 in the early- stage OA group was significantly higher than that in the late-stage OA group(P 〈0.01 ). Compared with the middle- stage OA group, MMP-1 had higher expression in the late-stage OA group and MMP-3 had higher expression in the ear- ly-stage OA group ( P 〈 0.05 ). ARGxx had a significantly higher level in the early-stage OA group ( P 〈 0.01 ). Con- versely, FFGxx had higher expression in the late-stage group than those in the early- and middle-stage groups ( P 〈 0.01 ). The exoression levels of ADAMTS-5, MMP-3 and ARGxx in the three groups were significantly higher thanthose of ADAMTS-4, MMP-1 and FFGxx respectively ( P 〈 0.01 ). Both ADAMTS-4 and -5 expressions were positive- ly correlated with ARGxx (P 〈0.01 ), and the expression of ADAMTS-4 was more closely related to it ( r =0.530 vs r = 0. 285 ). Western blot analysis revealed the expression of ADAMTS-4 significantly increased in the early-stage group ( P 〈0.05 ), while ADAMTS-5 had higher expression in both early-stage and late-stage groups ( P 〈 0.05 ). MMP-1 and FFGxx had higher expression in the late-stage group ( P 〈 0.05 ), while MMP-3 was higher in the early-stage group than in the middle-stage group ( P 〈 0.05 ). Besides, the expressions of ARGxx in early- and late-stage OA groups were significantly higher than that in the middle-stage group ( P 〈 0.05 ). Conclusion Aggrecanases are primarily involved in the cartilage destruction in the early and late stages of OA, however, matrix metalloproteinases mainly performed in the late stage of OA in human.
出处 《山东大学学报(医学版)》 CAS 北大核心 2012年第7期87-91,共5页 Journal of Shandong University:Health Sciences
基金 山东省自然科学基金(Y2007C132)
关键词 聚蛋白多糖酶 基质金属蛋白酶 骨关节炎 关节液 Aggrecanase Matrix metalloproteinase Osteoarthritis Synovial fluid
  • 相关文献

参考文献20

  • 1Martel-Pelletier J,Boileau C,Pelletier J P. Cartilage in normal and osteoarthritis conditions[J].Best Practice and Research:Clinical Rheumatology,2008,(02):351-384.
  • 2Song R H,Tortorella M D,Malfait A M. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5[J].Arthritis and Rheumatism,2007,(02):575-585.doi:10.1002/art.22334.
  • 3Bondeson J,Wainwright S,Hughes C. The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis:a review[J].Clinical and Experimental Rheumatology,2008,(01):139-145.
  • 4Takaishi H,Kimura T,Dalal S. Joint diseases and matrix metalloproteinases:a role for MMP-13[J].Current Pharmaceutical Biotechnology,2008,(01):47-54.doi:10.2174/138920108783497659.
  • 5Sandy J D. Proteolytic degradation of normal and osteoarthritic cartilage matrix[A].Oxford:Oxford University Press,2003.82-92.
  • 6Aktnab Rm,Asch E,Bloch G. Development of criteria for the classification and reporting of osteoarthritis:classification of osteoarthritis of the knee[J].Arthritis and Rheumatism,1986,(08):1039-1049.
  • 7Recht M P,Kramer J,Marcelis S. Abnormalities of articular cartilage in the knee:analysis of available MR techniques[J].Radiology,1993,(02):473-478.
  • 8Outerbridge R E. Further studies on the etiology of chondromalacia patellae[J].Journal of Bone and Joint Surgery-British Volume,1964,(02):179-190.
  • 9Hollander A P,Pidoux I,Reiner A. Damage to type Ⅱ collagen in aging and osteoarthritis starts at the articular surface,originates around chondrocytes,and extends into the cartilage with progressive degeneration[J].Journal of Clinical Investigation,1995,(06):2859-2869.doi:10.1172/JCI118357.
  • 10Wang M,Shen J,Jin H. Recent progress in understanding molecular mechanisms of cartilage degeneration during osteoarthritis[J].Annals of the New York Academy of Sciences,2011,(01):61-69.doi:10.1111/j.1749-6632.2011.06258.x.

二级参考文献5

  • 1Flannery CR, Lark MW, Sandy JD. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at the site in vivo in human articular cartilage. J Biol Chem, 1992, 267 : 1008-1014.
  • 2Sandy JD, Flannery CR, Neame PJ, et al. Tile structure of aggreean fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu373-Ala374 bond of the interglohular domain. J Clin Invest, 1992,89 : 1512-1516.
  • 3Abbaszade l, Liu RQ, Yang F, et al. Cloning and characlerization of ADAMTSI 1, an aggrecanase from the ADAMTS family. J Biol Chem, 1999, 274:23443-23450.
  • 4Stanton H, Fosang AJ. Matrix metalloproteinases are active following guanidine hydrochloride extraction of cartilage : generation of DIPEN neoepitope during dialysis. Matrix Biol, 2002, 21:425-428.
  • 5Glasson SS, Askew R, Sheppard B, et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature, 2005, 434:644-648.

共引文献3

同被引文献112

  • 1王国金,卫小春,张志强,纪斌平,毕树雄,刘巧玲.血清和关节液中基质金属蛋白酶-3及其抑制因子-1的检测及临床意义[J].中华风湿病学杂志,2006,10(5):311-313. 被引量:20
  • 2王玉彬,陈安民,郭风劲,夏玉军.基质金属蛋白酶家族在骨关节炎软骨组织中表达的研究[J].中国矫形外科杂志,2007,15(11):853-855. 被引量:34
  • 3Sundman EA, Cole BJ, Karas V, et al. The anti-inflammatory and matrix restorative mechanisms of platelet-rieh plasma in os- teoarthritis[J]. Am J Sports Med, 2014, 42(1):35-41.
  • 4Koskinen A, Vuoheenaho K, Moilanen T, et al. Resistin as a factor in osteoarthritis: synovial fluid resistin concentrations correlate positively with interleukin 6 and matrix metalloprotei- nases MMP-I and MMP-3[J]. Scand J Rheurnatol, 2014,43 (3) :249-253.
  • 5Valdes AM, Meulenbeh I, Chassaing E, et al. Large scale me- ta-analysis of urinary C-terminal telopeptide, serum cartilage oligomeric protein and matrix metalloprotease degraded type Ⅱ collagen and their role in prevalence, incidence and progression of osteoarthritis[J]. Osteoarthritis Cartilage, 2014, 22 (5) : 683-689.
  • 6Yang CC, Lin CY, Wang HS, et al Matrix metalloproteases and tissue inhibitors of metalloproteinases in medial plica and pannus-like tissue contribute to knee osteoarthritis progression [J]. PLoSOne, 2013, 8(11):e79662.
  • 7Choi YS, Park JK, Kang EH, et al. Cytokine signaling-1 sup- pressor is inducible by IL-1 beta and inhibits the catabolic effects of IL-lbeta in chondrocytes: its implication in the paradoxical joint-protective role of IL-ibeta[J]. Arthritis Res Ther, 2013, 15(6) :R191.
  • 8Wang Z, Qiu Y, Lu J, et al. Connective tissue growth factor promotes interleukin-1β-mediated synovial inflammation in knee osteoarthritis[J]. Mol Med Rep, 2013,8(3) :877-882.
  • 9MeNulty AL, Rothfusz NE, Leddy HA, et al. Synovial fluid concentrations and relative potency of interleukin-1 alpha and beta in cartilage and meniscus degradation[J]. J Orthop Res, 2013, 31(7) :1039-1045.
  • 10Wil ian Hunter. Of the structure and disease of the articular cartilage[J].{H}Clinical Orthopaedics,2006,(03):317.

引证文献6

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部